Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$4.055
Market cap
$83.54M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.13
Enterprise value
$38.86M
Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct
Highlights
The company's net income has surged by 66% QoQ
Petmed Express's EPS has surged by 65% QoQ
The quick ratio has contracted by 25% YoY but it has grown by 2.5% from the previous quarter
The revenue has contracted by 3.7% from the previous quarter but it has grown by 2.3% YoY
The equity has declined by 21% year-on-year and by 3.3% since the previous quarter
PETS's gross profit is down by 6% since the previous quarter
Key stats
What are the main financial stats of PETS
Market
Valuations
Earnings
Shares outstanding
20.6M
Market cap
$83.54M
Enterprise value
$38.86M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.89
Price to sales (P/S)
0.31
EV/EBIT
N/A
EV/EBITDA
6.17
EV/Sales
0.14
Revenue
$270.77M
EBIT
-$795,000
EBITDA
$6.3M
Free cash flow
-$8.8M
Per share
Balance sheet
Liquidity
EPS
-$0.13
Free cash flow per share
-$0.43
Book value per share
$4.54
Revenue per share
$13.2
TBVPS
$5.36
Total assets
$152.71M
Total liabilities
$59.18M
Debt
$1.32M
Equity
$93.53M
Working capital
$19.32M
Debt to equity
0.01
Current ratio
1.33
Quick ratio
0.83
Net debt/EBITDA
-7.09
Margins
Efficiency
Dividend
EBITDA margin
2.3%
Gross margin
27.4%
Net margin
-1%
Operating margin
-0.6%
Return on assets
-1.6%
Return on equity
-2.6%
Return on invested capital
-13.7%
Return on capital employed
-0.8%
Return on sales
-0.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PETS stock price
How has the Petmed Express stock price performed over time
Intraday
-0.61%
1 week
3.97%
1 month
10.19%
1 year
-55.83%
YTD
-46.36%
QTD
10.19%
Financial performance
How have Petmed Express's revenue and profit performed over time
Revenue
$270.77M
Gross profit
$74.09M
Operating income
-$1.65M
Net income
-$2.57M
Gross margin
27.4%
Net margin
-1%
The operating income has soared by 80% from the previous quarter
The company's operating margin has surged by 79% QoQ
The company's net income has surged by 66% QoQ
PETS's net margin has surged by 63% since the previous quarter
Growth
What is Petmed Express's growth rate over time
Valuation
What is Petmed Express stock price valuation
P/E
N/A
P/B
0.89
P/S
0.31
EV/EBIT
N/A
EV/EBITDA
6.17
EV/Sales
0.14
Petmed Express's EPS has surged by 65% QoQ
The price to book (P/B) is 74% lower than the 5-year quarterly average of 3.4 and 36% lower than the last 4 quarters average of 1.4
The equity has declined by 21% year-on-year and by 3.3% since the previous quarter
The P/S is 79% below the 5-year quarterly average of 1.5 and 38% below the last 4 quarters average of 0.5
The revenue has contracted by 3.7% from the previous quarter but it has grown by 2.3% YoY
Efficiency
How efficient is Petmed Express business performance
Petmed Express's return on sales has shrunk by 133% YoY but it has surged by 88% QoQ
The ROIC has soared by 79% from the previous quarter
PETS's ROE has soared by 64% from the previous quarter
The company's return on assets has surged by 63% QoQ
Dividends
What is PETS's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Petmed Express financials performed over time
Petmed Express's total assets is 158% more than its total liabilities
The current ratio has contracted by 28% YoY but it has grown by 2.3% from the previous quarter
The quick ratio has contracted by 25% YoY but it has grown by 2.5% from the previous quarter
PETS's debt is 99% smaller than its equity
The company's debt to equity has shrunk by 50% QoQ and by 50% YoY
PETS's debt is down by 36% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.